2-118970242-G-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_006770.4(MARCO):c.328G>A(p.Ala110Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000342 in 1,461,832 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_006770.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MARCO | NM_006770.4 | c.328G>A | p.Ala110Thr | missense_variant | 3/17 | ENST00000327097.5 | NP_006761.1 | |
MARCO | XM_011512082.3 | c.328G>A | p.Ala110Thr | missense_variant | 3/17 | XP_011510384.1 | ||
MARCO | XM_017005171.3 | c.328G>A | p.Ala110Thr | missense_variant | 3/9 | XP_016860660.1 | ||
MARCO | XM_011512083.4 | c.98-4091G>A | intron_variant | XP_011510385.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MARCO | ENST00000327097.5 | c.328G>A | p.Ala110Thr | missense_variant | 3/17 | 1 | NM_006770.4 | ENSP00000318916 | P1 | |
MARCO | ENST00000412481.1 | c.94G>A | p.Ala32Thr | missense_variant | 4/4 | 4 | ENSP00000409192 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome AF: 0.00000342 AC: 5AN: 1461832Hom.: 0 Cov.: 32 AF XY: 0.00000275 AC XY: 2AN XY: 727222
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 14, 2023 | The c.328G>A (p.A110T) alteration is located in exon 3 (coding exon 3) of the MARCO gene. This alteration results from a G to A substitution at nucleotide position 328, causing the alanine (A) at amino acid position 110 to be replaced by a threonine (T). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at